Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-525
Closed -$55K 2246
2020
Q3
$55K Hold
525
﹤0.01% 1951
2020
Q2
$135K Buy
525
+42
+9% +$16K ﹤0.01% 1726
2020
Q1
$215K Hold
483
﹤0.01% 1525
2019
Q4
$326K Hold
483
﹤0.01% 1573
2019
Q3
$178K Buy
483
+416
+621% +$135K ﹤0.01% 1674
2019
Q2
$11K Buy
+67
New +$13.9K ﹤0.01% 2073

Other funds holding NXTC

STRS Ohio's NXTC Position: Q4 2020 in Review

STRS Ohio sold out of NextCure (NXTC) in Q4 2020, closing a stake of 525 shares — an estimated $55K sold.

STRS Ohio first reported a position in NXTC in Q2 2019 and held it in 6 quarters. The position peaked at $326K in Q4 2019. 83 funds tracked by Wall St. Rank hold NXTC as of Q4 2020.

  • STRS Ohio reported no remaining NextCure position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 525 NextCure shares in Q4 2020, an estimated $55K.
  • STRS Ohio first reported a position in NextCure in Q2 2019 and held it in 6 quarters.
  • STRS Ohio's NextCure position peaked at $326K in Q4 2019.
  • 83 funds tracked by Wall St. Rank held NextCure as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.